Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Lehmann

Showing results (131-140 of 210) with videos related to

Pageof 21
Sort By:
Pediatric Blood & Cancer|March 20, 2015
A child with Li-Fraumeni syndrome: Modes to inactivate the second allele of TP53 in three different malignanciesBrigitte Schlegelberger, Hans Kreipe, Ulrich Lehmann, et al.
Applied Clinical Informatics|May 21, 2026
Beyond the Model: Practical Insights from Monitoring Predictive Models Across Diverse Clinical WorkflowsJohn J Hanna, Christopher R Dennis, Andrew O Johnson, et al.
BMC Cancer|March 25, 2010
Identification of differentially expressed microRNAs in human male breast cancerUlrich Lehmann, Thomas Streichert, Benjamin Otto, et al.
Human Molecular Genetics|April 7, 2007
Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosisUlrich Lehmann, Luzie U Wingen, Kai Brakensiek, et al.
Cell Death & Disease|July 27, 2021
BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatmentStephanie Busche, Katharina John, Franziska Wandrer, et al.
Applied Clinical Informatics|March 24, 2025
Implementation and Adoption of an Order-Based Surgical Case Request Tool Across Subspecialty ClinicsAndrew Patrick Bain, Alyssa Low, Robert W Turer, et al.
BMC Gastroenterology|May 20, 2015
Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case reportPhilipp Solbach, Andrej Potthoff, Hans-Jürgen Raatschen, et al.
Gastroenterology|April 17, 2007
Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver diseaseAndré Lechel, Henne Holstege, Yvonne Begus, et al.
Genes, Chromosomes & Cancer|December 7, 2018
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profilingMatthias Christgen, Stephan Bartels, Martin Radner, et al.
Breast Cancer Research and Treatment|June 5, 2003
Expression profiling of breast cancer cells by differential peptide displayHarald Tammen, Hans Kreipe, Rüdiger Hess, et al.
Pageof 21

Showing results (131-140 of 210) with videos related to

Sort By:
Pageof 21
Pediatric Blood & Cancer|March 20, 2015
A child with Li-Fraumeni syndrome: Modes to inactivate the second allele of TP53 in three different malignanciesBrigitte Schlegelberger, Hans Kreipe, Ulrich Lehmann, et al.
Applied Clinical Informatics|May 21, 2026
Beyond the Model: Practical Insights from Monitoring Predictive Models Across Diverse Clinical WorkflowsJohn J Hanna, Christopher R Dennis, Andrew O Johnson, et al.
BMC Cancer|March 25, 2010
Identification of differentially expressed microRNAs in human male breast cancerUlrich Lehmann, Thomas Streichert, Benjamin Otto, et al.
Human Molecular Genetics|April 7, 2007
Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosisUlrich Lehmann, Luzie U Wingen, Kai Brakensiek, et al.
Cell Death & Disease|July 27, 2021
BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatmentStephanie Busche, Katharina John, Franziska Wandrer, et al.
Applied Clinical Informatics|March 24, 2025
Implementation and Adoption of an Order-Based Surgical Case Request Tool Across Subspecialty ClinicsAndrew Patrick Bain, Alyssa Low, Robert W Turer, et al.
BMC Gastroenterology|May 20, 2015
Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case reportPhilipp Solbach, Andrej Potthoff, Hans-Jürgen Raatschen, et al.
Gastroenterology|April 17, 2007
Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver diseaseAndré Lechel, Henne Holstege, Yvonne Begus, et al.
Genes, Chromosomes & Cancer|December 7, 2018
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profilingMatthias Christgen, Stephan Bartels, Martin Radner, et al.
Breast Cancer Research and Treatment|June 5, 2003
Expression profiling of breast cancer cells by differential peptide displayHarald Tammen, Hans Kreipe, Rüdiger Hess, et al.
Pageof 21